Home
>
National Drug Code (NDC)
>
ADVAIR HFA
ADVAIR HFA - 0173-0717-20 - (fluticasone propionate and salmeterol xinafoate)
Drug Information of ADVAIR HFA
| Product NDC: | 0173-0717 |
| Proprietary Name: | ADVAIR HFA |
| Non Proprietary Name: | fluticasone propionate and salmeterol xinafoate |
| Active Ingredient(s): | 230; 21 ug/1; ug/1 & nbsp; fluticasone propionate and salmeterol xinafoate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | AEROSOL, METERED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ADVAIR HFA
| Product NDC: | 0173-0717 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021254 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090306 |
Package Information of ADVAIR HFA
| Package NDC: | 0173-0717-20 |
| Package Description: | 120 AEROSOL, METERED in 1 INHALER (0173-0717-20) |
NDC Information of ADVAIR HFA
| NDC Code | 0173-0717-20 |
| Proprietary Name | ADVAIR HFA |
| Package Description | 120 AEROSOL, METERED in 1 INHALER (0173-0717-20) |
| Product NDC | 0173-0717 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluticasone propionate and salmeterol xinafoate |
| Dosage Form Name | AEROSOL, METERED |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20090306 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| Strength Number | 230; 21 |
| Strength Unit | ug/1; ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
